• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
MEM 0.00% 0.5¢

MEMPHASYS LIMITED. - Announcements

Memphasys Limited is an Australia-based reproductive biotechnology company. The Company... Memphasys Limited is an Australia-based reproductive biotechnology company. The Company is engaged in developing medical devices, diagnostics, and media with application to assisted reproductive technology (ART) in humans and animals. The Company's product pipeline includes Felix, RoXsta, and AI-Port. Its advanced product, the Felix System, is a patented automated device for quickly and gently separating sperm from a semen sample for use in ART procedures. The Felix device consists of two main components: a console, which supplies electrical power, and a sterile disposable cartridge for sperm isolation and selection. RoXsta is an in-vitro diagnostic device that assesses semen and other bodily fluids for oxidative stress load. RoXsta also has an application as part of a suite of products that can support the animal industry. AI-Port has been developed for the purpose of maintaining the viability of livestock semen for up to seven days at a temperature range of 22 - 25 degrees Celsius.More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Announcements


Plus500
Plus500
ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
Plus500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk

MEMAppendix 3B11/12/09
MEMLetter from the Chairman10/12/09
MEMNuSep Increases Profit Forecast to $1m -Broadcast10/12/09
MEMIncreases Profit Forecast to $1m after it Acquires BioInquirPRICE SENSITIVE09/12/09
MEMTrading HaltPRICE SENSITIVE07/12/09
MEMAppendix 3B Issue of Bonus loyalty shares07/12/09
MEMChange in substantial holding03/12/09
MEMNuSep 2009 AGM Presentation30/11/09
MEMResults of AGM30/11/09
MEMChange in substantial holding30/11/09
MEMChange in substantial holding25/11/09
MEMOn Track after 1st Quarter Broadcast24/11/09
MEMChange in substantial holding23/11/09
MEMNuSep On Track after 1st QuarterPRICE SENSITIVE23/11/09
MEMBecoming a substantial holder20/11/09
MEMSubstantial Shareholder Announcement18/11/09
MEMRecovery of $636,000 from NxGenPRICE SENSITIVE17/11/09
MEMAGM Update17/11/09
MEMSpermSep Australian Patent GrantedPRICE SENSITIVE09/11/09
MEMNotice of Annual General Meeting/Proxy Form.02/11/09
MEMNuSep Annual Report 200930/10/09
MEMAppendix 3Y x422/10/09
MEMAppendix 3B16/10/09
MEMFull Year Statutory Accounts01/10/09
MEMChange of Director's Interest Notice21/09/09
MEMSPO Appendix 3B14/09/09
MEMNuSep raises $3.75m following conversion of Director LoansPRICE SENSITIVE14/09/09
MEMNuSep Raised $2.8m via SPO14/09/09
MEMChange of Director's Interest Notice11/09/09
MEMNuSep Results of Meeting09/09/09
MEMChange of Director's Interest Notice07/09/09
MEMNuSep Investor Presentation04/09/09
MEMChange of Director's Interest Notice04/09/09
MEMNuSep Share Purchase Offer Closing on Friday 4th Sept 200902/09/09
MEMNuSep Shareholder Newsletter Sept 2009PRICE SENSITIVE01/09/09
MEMNuSep Director Share Purchases and Shareholder Lunch Meeting31/08/09
MEMNuSep Preliminary Final Report 30 June 2009PRICE SENSITIVE28/08/09
MEMNuSep Director Share Purchases21/08/09
MEMNuSep Investor Presentations20/08/09
MEM30 June 2010 Forecast $500,000 Net ProfitPRICE SENSITIVE18/08/09
MEMNuSep Director Share Purchases18/08/09
MEMAppendix 3B17/08/09
MEMDirector Share Purchases and Shareholder Lunch Meetings17/08/09
MEMNuSep Company Overview14/08/09
MEMNotice of Extraordinary General Meeting/Proxy Form11/08/09
MEMSPO Prospectus and Market UpdatePRICE SENSITIVE10/08/09
MEMNuSep Lodges $2m SPO ProspectusPRICE SENSITIVE06/08/09
MEMNuSep Confirms $1m Underwriting of SPO29/07/09
MEMNuSep Lodges Supplementary Prospectus29/07/09
MEMNuSep lodges Share Purchase Offer22/07/09
MEMNSP 1 for 20 Share Consolidation10/07/09
MEMNSP Letter from the Chairman10/07/09
MEMReinstatement to Official QuotationPRICE SENSITIVE09/07/09
MEMGels Business Achieves Profitability And Announcement of SPP02/07/09
MEMInitial Director's Interest Notice02/07/09
MEMNSP Appointment of a New Director02/07/09
MEMClose of Prospectus and Cancelation of the NxGen Acquisition30/06/09
MEMChange of Address Registered Office16/06/09
MEMNSP Extension of Prospectus Closing Date12/06/09
MEMNxGen Newsletter05/06/09
MEMNuSep Results of EGM02/06/09
MEMExtension of Prospectus Closing Date / Administration Update29/05/09
MEMDisclosure Document29/05/09
MEMNxGen Commences US Expansion26/05/09
MEMAMI Media Articles25/05/09
MEMExtension of Prospectus Closing Date22/05/09
MEMNxGen Acquisition Prospectus dated 7 May 0907/05/09
MEMNotice of Extraordinary General Meeting/Proxy Form06/05/09
MEMReplacement Prospectus20/03/09
MEMASX Circular - Reorganisation of Capital13/03/09
MEMSuspension from Official QuotationPRICE SENSITIVE13/03/09
MEMNuSep Results of EGM13/03/09
MEMNuSep EGM Presentation13/03/09
MEMTrading HaltPRICE SENSITIVE13/03/09
MEMProspectus To Acquire NxGenPRICE SENSITIVE11/03/09
MEMNuSep Half Year Report and AccountsPRICE SENSITIVE27/02/09
MEMNSP Value of Acquisition of NxGen18/02/09
MEMNotice of Extraordinary General Meeting/Proxy Form13/02/09
MEMAppendix 3B10/02/09
MEMAppendix 3B29/12/08
MEMAppendix 3B08/12/08
MEMNSP NxGen Acquisition Update02/12/08
MEMSigns Binding Agreement to Acquire NxGenPRICE SENSITIVE01/12/08
MEMNuSep AGM Presentation28/11/08
MEMNSP Results of AGM28/11/08
MEMAppendix 3B
11/12/09
MEMLetter from the Chairman
10/12/09
MEMNuSep Increases Profit Forecast to $1m -Broadcast
10/12/09
MEMIncreases Profit Forecast to $1m after it Acquires BioInquir
09/12/09PRICE SENSITIVE
MEMTrading Halt
07/12/09PRICE SENSITIVE
MEMAppendix 3B Issue of Bonus loyalty shares
07/12/09
MEMChange in substantial holding
03/12/09
MEMNuSep 2009 AGM Presentation
30/11/09
MEMResults of AGM
30/11/09
MEMChange in substantial holding
30/11/09
MEMChange in substantial holding
25/11/09
MEMOn Track after 1st Quarter Broadcast
24/11/09
MEMChange in substantial holding
23/11/09
MEMNuSep On Track after 1st Quarter
23/11/09PRICE SENSITIVE
MEMBecoming a substantial holder
20/11/09
MEMSubstantial Shareholder Announcement
18/11/09
MEMRecovery of $636,000 from NxGen
17/11/09PRICE SENSITIVE
MEMAGM Update
17/11/09
MEMSpermSep Australian Patent Granted
09/11/09PRICE SENSITIVE
MEMNotice of Annual General Meeting/Proxy Form.
02/11/09
MEMNuSep Annual Report 2009
30/10/09
MEMAppendix 3Y x4
22/10/09
MEMAppendix 3B
16/10/09
MEMFull Year Statutory Accounts
01/10/09
MEMChange of Director's Interest Notice
21/09/09
MEMSPO Appendix 3B
14/09/09
MEMNuSep raises $3.75m following conversion of Director Loans
14/09/09PRICE SENSITIVE
MEMNuSep Raised $2.8m via SPO
14/09/09
MEMChange of Director's Interest Notice
11/09/09
MEMNuSep Results of Meeting
09/09/09
MEMChange of Director's Interest Notice
07/09/09
MEMNuSep Investor Presentation
04/09/09
MEMChange of Director's Interest Notice
04/09/09
MEMNuSep Share Purchase Offer Closing on Friday 4th Sept 2009
02/09/09
MEMNuSep Shareholder Newsletter Sept 2009
01/09/09PRICE SENSITIVE
MEMNuSep Director Share Purchases and Shareholder Lunch Meeting
31/08/09
MEMNuSep Preliminary Final Report 30 June 2009
28/08/09PRICE SENSITIVE
MEMNuSep Director Share Purchases
21/08/09
MEMNuSep Investor Presentations
20/08/09
MEM30 June 2010 Forecast $500,000 Net Profit
18/08/09PRICE SENSITIVE
MEMNuSep Director Share Purchases
18/08/09
MEMAppendix 3B
17/08/09
MEMDirector Share Purchases and Shareholder Lunch Meetings
17/08/09
MEMNuSep Company Overview
14/08/09
MEMNotice of Extraordinary General Meeting/Proxy Form
11/08/09
MEMSPO Prospectus and Market Update
10/08/09PRICE SENSITIVE
MEMNuSep Lodges $2m SPO Prospectus
06/08/09PRICE SENSITIVE
MEMNuSep Confirms $1m Underwriting of SPO
29/07/09
MEMNuSep Lodges Supplementary Prospectus
29/07/09
MEMNuSep lodges Share Purchase Offer
22/07/09
MEMNSP 1 for 20 Share Consolidation
10/07/09
MEMNSP Letter from the Chairman
10/07/09
MEMReinstatement to Official Quotation
09/07/09PRICE SENSITIVE
MEMGels Business Achieves Profitability And Announcement of SPP
02/07/09
MEMInitial Director's Interest Notice
02/07/09
MEMNSP Appointment of a New Director
02/07/09
MEMClose of Prospectus and Cancelation of the NxGen Acquisition
30/06/09
MEMChange of Address Registered Office
16/06/09
MEMNSP Extension of Prospectus Closing Date
12/06/09
MEMNxGen Newsletter
05/06/09
MEMNuSep Results of EGM
02/06/09
MEMExtension of Prospectus Closing Date / Administration Update
29/05/09
MEMDisclosure Document
29/05/09
MEMNxGen Commences US Expansion
26/05/09
MEMAMI Media Articles
25/05/09
MEMExtension of Prospectus Closing Date
22/05/09
MEMNxGen Acquisition Prospectus dated 7 May 09
07/05/09
MEMNotice of Extraordinary General Meeting/Proxy Form
06/05/09
MEMReplacement Prospectus
20/03/09
MEMASX Circular - Reorganisation of Capital
13/03/09
MEMSuspension from Official Quotation
13/03/09PRICE SENSITIVE
MEMNuSep Results of EGM
13/03/09
MEMNuSep EGM Presentation
13/03/09
MEMTrading Halt
13/03/09PRICE SENSITIVE
MEMProspectus To Acquire NxGen
11/03/09PRICE SENSITIVE
MEMNuSep Half Year Report and Accounts
27/02/09PRICE SENSITIVE
MEMNSP Value of Acquisition of NxGen
18/02/09
MEMNotice of Extraordinary General Meeting/Proxy Form
13/02/09
MEMAppendix 3B
10/02/09
MEMAppendix 3B
29/12/08
MEMAppendix 3B
08/12/08
MEMNSP NxGen Acquisition Update
02/12/08
MEMSigns Binding Agreement to Acquire NxGen
01/12/08PRICE SENSITIVE
MEMNuSep AGM Presentation
28/11/08
MEMNSP Results of AGM
28/11/08
(20min delay)
Last
0.5¢
Change
0.000(0.00%)
Mkt cap ! $13.00M
Open High Low Value Volume
0.5¢ 0.5¢ 0.5¢ $12.5K 2.5M

Buyers (Bids)

No. Vol. Price($)
4 4139600 0.5¢
 

Sellers (Offers)

Price($) Vol. No.
0.6¢ 11066843 9
View Market Depth
Last trade - 15.45pm 29/11/2024 (20 minute delay) ?
Last
0.5¢
  Change
0.000 ( 0.00 %)
Open High Low Volume
0.5¢ 0.5¢ 0.5¢ 200000
Last updated 14.07pm 29/11/2024 ?
MEM (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.